On Target Laboratories: Making Light Work of Cancer Resection

article image

Surgeons' go-to means of sensing cancer uses only the hands and the naked eye, resulting in imperfect outcomes and more procedures, both diagnostic and interventional, down the line. On Target Laboratories has formulated a fluorescent marker that attaches to cancer cells to minimize uncertainty from detection and enable more complete resections.

Nearly everyone knows someone who has been diagnosed with cancer. Though patient outcomes vary and many do recover after a complete tumor removal, cancer is still a leading cause of death in the US, with lung, breast, and prostate accounting for the highest mortality rates.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: